Elke Neumann‐Haefelin

1.9k total citations · 1 hit paper
39 papers, 1.3k citations indexed

About

Elke Neumann‐Haefelin is a scholar working on Molecular Biology, Aging and Cancer Research. According to data from OpenAlex, Elke Neumann‐Haefelin has authored 39 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 10 papers in Aging and 10 papers in Cancer Research. Recurrent topics in Elke Neumann‐Haefelin's work include Genetics, Aging, and Longevity in Model Organisms (10 papers), Cancer, Hypoxia, and Metabolism (9 papers) and Circadian rhythm and melatonin (8 papers). Elke Neumann‐Haefelin is often cited by papers focused on Genetics, Aging, and Longevity in Model Organisms (10 papers), Cancer, Hypoxia, and Metabolism (9 papers) and Circadian rhythm and melatonin (8 papers). Elke Neumann‐Haefelin collaborates with scholars based in Germany, United States and Switzerland. Elke Neumann‐Haefelin's co-authors include T. Keith Blackwell, Masaki Mizunuma, Dudley W. Lamming, Stacey Robida-Stubbs, David M. Sabatini, Kira Glover-Cutter, Sri Devi Narasimhan, Gerd Walz, Ralf Baumeister and Tobias B. Huber and has published in prestigious journals such as Journal of Biological Chemistry, Nature Genetics and Genes & Development.

In The Last Decade

Elke Neumann‐Haefelin

36 papers receiving 1.3k citations

Hit Papers

TOR Signaling and Rapamycin Influence Longevity by Regula... 2012 2026 2016 2021 2012 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. TOR Signaling and Rapamycin Influence Longevity by Regulating SKN-1/Nrf and DAF-16/FoxO
    2012 504 citations Stacey Robida-Stubbs, Kira Glover-Cutter et al. Cell Metabolism profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elke Neumann‐Haefelin Germany 19 748 530 225 221 174 39 1.3k
Sheng‐Fung Lin Taiwan 21 417 0.6× 116 0.2× 493 2.2× 279 1.3× 51 0.3× 44 1.3k
Sophie Brûlé Canada 10 1.3k 1.7× 104 0.2× 69 0.3× 436 2.0× 17 0.1× 11 1.8k
Chisaka Kuehnemann United States 9 689 0.9× 186 0.4× 59 0.3× 798 3.6× 13 0.1× 10 1.5k
Rhys Anderson United Kingdom 6 571 0.8× 252 0.5× 58 0.3× 819 3.7× 12 0.1× 6 1.3k
Yariv Kanfi Israel 13 661 0.9× 248 0.5× 78 0.3× 753 3.4× 11 0.1× 15 1.8k
Sharon Olijslagers United Kingdom 8 572 0.8× 153 0.3× 38 0.2× 539 2.4× 12 0.1× 9 1.1k
Bingrong Liu China 15 819 1.1× 286 0.5× 78 0.3× 282 1.3× 5 0.0× 28 1.4k
Hak Joo Lee United States 14 370 0.5× 30 0.1× 86 0.4× 195 0.9× 51 0.3× 20 826
Xiaoping Zhu China 17 857 1.1× 147 0.3× 50 0.2× 124 0.6× 7 0.0× 28 1.4k

Countries citing papers authored by Elke Neumann‐Haefelin

Since Specialization
Citations

This map shows the geographic impact of Elke Neumann‐Haefelin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elke Neumann‐Haefelin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elke Neumann‐Haefelin more than expected).

Fields of papers citing papers by Elke Neumann‐Haefelin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elke Neumann‐Haefelin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elke Neumann‐Haefelin. The network helps show where Elke Neumann‐Haefelin may publish in the future.

Co-authorship network of co-authors of Elke Neumann‐Haefelin

This figure shows the co-authorship network connecting the top 25 collaborators of Elke Neumann‐Haefelin. A scholar is included among the top collaborators of Elke Neumann‐Haefelin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elke Neumann‐Haefelin. Elke Neumann‐Haefelin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ganner, Athina, Sonam Dhamija, Ian J. Frew, et al.. (2025). Nonstop mutations cause loss of renal tumor suppressor proteins VHL and BAP1 and affect multiple stages of protein translation. Science Advances. 11(7). eadr6375–eadr6375. 1 indexed citations
3.
Neidert, Nicolas, Elke Neumann‐Haefelin, Athina Ganner, et al.. (2024). Screening and surveillance recommendations for central nervous system hemangioblastomas in pediatric patients with Von Hippel-Lindau disease. Journal of Neuro-Oncology. 168(3). 537–545. 2 indexed citations
4.
Ganner, Athina, Laura Cubitt, Dong‐Kyu Kim, et al.. (2024). Saturation genome editing maps the functional spectrum of pathogenic VHL alleles. Nature Genetics. 56(7). 1446–1455. 16 indexed citations
5.
Klein, Marinella, et al.. (2024). VHL-dependence of EHHADH Expression in a Human Renal Cell Carcinoma Cell Line. SHILAP Revista de lepidopterología. 11(1). 12–18. 2 indexed citations
6.
Klingler, Jan‐Helge, Nicolas Neidert, Elke Neumann‐Haefelin, et al.. (2024). Intraoperative indocyanine green (ICG) videoangiography in spinal hemangioblastoma surgery - helpful tool or unnecessary?. Clinical Neurology and Neurosurgery. 248. 108661–108661.
7.
Ganner, Athina, Simon Lagies, Lu Wang, et al.. (2023). SCD5 Regulation by VHL Affects Cell Proliferation and Lipid Homeostasis in ccRCC. Cells. 12(6). 835–835. 4 indexed citations
8.
Welte, Thomas, et al.. (2023). Eculizumab as a treatment for C3 glomerulopathy: a single-center retrospective study. BMC Nephrology. 24(1). 8–8. 13 indexed citations
9.
Kirste, Simon, Alexander Rühle, Stefan Zschiedrich, et al.. (2022). Stereotactic Body Radiotherapy for Renal Cell Carcinoma in Patients with Von Hippel–Lindau Disease—Results of a Prospective Trial. Cancers. 14(20). 5069–5069. 9 indexed citations
10.
Ganner, Athina, Christina Gehrke, Marinella Klein, et al.. (2021). VHL suppresses RAPTOR and inhibits mTORC1 signaling in clear cell renal cell carcinoma. Scientific Reports. 11(1). 14827–14827. 29 indexed citations
11.
Kotsis, Fruzsina, Yujie Li, Amandine Viau, et al.. (2021). Ift88, but not Kif3a, is required for establishment of the periciliary membrane compartment. Biochemical and Biophysical Research Communications. 584. 19–25. 1 indexed citations
12.
Rieg, Siegbert, Elke Neumann‐Haefelin, Paul Biever, et al.. (2020). Comparison of different anticoagulation strategies for renal replacement therapy in critically ill patients with COVID-19: a cohort study. BMC Nephrology. 21(1). 20 indexed citations
13.
Neumann‐Haefelin, Elke, Eugen Widmeier, Kai Kaufmann, et al.. (2020). Subcutaneous Enoxaparin Safely Facilitates Bedside Sustained Low-Efficiency Hemodialysis in Hypercoagulopathic Coronavirus Disease 2019 Patients—A Proof-of-Principle Trial. Critical Care Explorations. 2(6). e0155–e0155. 2 indexed citations
14.
Ganner, Athina, et al.. (2020). The acetyltransferase p300 regulates NRF2 stability and localization. Biochemical and Biophysical Research Communications. 524(4). 895–902. 48 indexed citations
15.
Prentzell, Mirja Tamara, Birgit Holzwarth, Kathrin Kläsener, et al.. (2015). TSC1 Activates TGF-β-Smad2/3 Signaling in Growth Arrest and Epithelial-to-Mesenchymal Transition. Developmental Cell. 32(5). 617–630. 52 indexed citations
16.
Dottermusch, Matthias, et al.. (2015). Caenorhabditis elegans OSM-11 signaling regulates SKN-1/Nrf during embryonic development and adult longevity and stress response. Developmental Biology. 400(1). 118–131. 15 indexed citations
17.
Walz, Gerd, et al.. (2013). TORC2 signaling antagonizes SKN-1 to induce C. elegans mesendodermal embryonic development. Developmental Biology. 384(2). 214–227. 19 indexed citations
18.
Robida-Stubbs, Stacey, Kira Glover-Cutter, Dudley W. Lamming, et al.. (2012). TOR Signaling and Rapamycin Influence Longevity by Regulating SKN-1/Nrf and DAF-16/FoxO. Cell Metabolism. 15(5). 713–724. 504 indexed citations breakdown →
19.
Qi, Wenjing, Xu‐Feng Huang, Elke Neumann‐Haefelin, Ekkehard Schulze, & Ralf Baumeister. (2012). Cell-Nonautonomous Signaling of FOXO/DAF-16 to the Stem Cells of Caenorhabditis elegans. PLoS Genetics. 8(8). e1002836–e1002836. 29 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sheng‐Fung Lin Breakdown of academic impact, for papers by Sophie Brûlé Breakdown of academic impact, for papers by Chisaka Kuehnemann Breakdown of academic impact, for papers by Rhys Anderson Breakdown of academic impact, for papers by Yariv Kanfi Breakdown of academic impact, for papers by Sharon Olijslagers Breakdown of academic impact, for papers by Bingrong Liu Breakdown of academic impact, for papers by Hak Joo Lee Breakdown of academic impact, for papers by Xiaoping Zhu
Rankless by CCL
2026